Business Context and Reporting Period
This Form 8-K Current Report was filed by Nukkleus Inc. (not T3 Defense Inc.) on September 19, 2025. The filing discloses the entry into a Material Definitive Agreement regarding an Equity Line of Credit (ELOC) and the unregistered sale of equity securities.
Key Financial Metrics and Transaction Details
- Total Commitment: The Company may sell up to the lesser of $250,000,000 or the "Exchange Cap" (19.99% of outstanding common stock immediately prior to execution).
- Commitment Shares: Upon execution, the Company issued $1,250,000 worth of Common Stock to the investor (Esousa Group Holdings, LLC).
- Pricing Mechanism: Future shares will be sold at 97.5% of the lower of the lowest daily VWAP of the preceding three trading days or the closing sale price on the purchase date.
- Volume Limitations: Daily sales cannot exceed 20% of the trading volume on the applicable purchase date.
- Ownership Cap: The investor cannot acquire more than 9.99% of outstanding shares without additional approval.
- Term: The agreement is effective for 36 months following the effective date of the registration rights agreement.
- Use of Proceeds: Working capital and general corporate purposes.
Note: The filing does not provide specific revenue, profit, cash flow, margin, or debt figures for the reporting period.
Material Changes
The primary material change is the establishment of a new financing facility. The Company has secured a potential source of up to $250 million in capital, subject to market conditions and volume limits. This represents a shift in liquidity strategy, providing flexibility to raise capital over time rather than through a single issuance.
Guidance, Outlook, and Risks
- Management Commentary: Management believes the ELOC provides necessary flexibility to sell shares subject to market conditions.
- Risks and Contingencies:
- Dilution: Issuance of shares up to 19.99% of outstanding stock will dilute existing shareholders.
- Market Volatility: The actual proceeds depend on the frequency of sales and share prices, which are subject to market fluctuations.
- Investor Discretion: While the investor is obligated to purchase upon direction, the Company has no obligation to sell, and sales are subject to Nasdaq listing rules and beneficial ownership limits.
Key Facts for Investor Verification
- Verify the exact number of shares issued for the initial $1,250,000 Commitment Shares based on the effective date VWAP.
- Confirm the current outstanding share count to calculate the precise dollar value of the 19.99% Exchange Cap.
- Monitor the status of the registration statement required for the resale of shares under the ELOC RRA.
- Review the full text of the Common Stock Purchase Agreement (Exhibit 10.1) for specific termination rights and conditions.